Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

111
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
111
Positron Emission Tomography01:29

Positron Emission Tomography

4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Avatar: Personalized Precision Radio-Genomic Theranostic Oncology.

Cancer biotherapy & radiopharmaceuticals·2025
Same author

Intuitive Human-Artificial Intelligence Theranostic Complementarity.

Cancer biotherapy & radiopharmaceuticals·2025
Same author

Human-Artificial Intelligence Symbiotic Reporting for Theranostic Cancer Care.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Theranostics, Advanced Cancer, and The Meaning of Life.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Theranostic Innovation by Humane N-of-One Cancer Care in Real-World Patients.

Cancer biotherapy & radiopharmaceuticals·2024
Same author

Triangle of Trust in Cancer Care? The Physician, the Patient, and Artificial Intelligence Chatbot.

Cancer biotherapy & radiopharmaceuticals·2023

相关实验视频

Updated: Jun 26, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.8K

热诺斯蒂克:时机就是一切

J Harvey Turner1

  • 1Department of Nuclear Medicine, Fiona Stanley Fremantle Hospitals Group, The University of Western Australia, Murdoch, Australia.

Cancer biotherapy & radiopharmaceuticals
|May 17, 2024
PubMed
概括
此摘要是机器生成的。

时间对于在癌症治疗中推进分子向放射性干疗法至关重要. 精确的剂量和组合治疗是有效的治疗术的关键,标志着核医学的新时代.

关键词:
剂量测量方法 剂量测量方法弗罗尼西斯就是这样的.放射性配方FAPI胰腺癌治疗疗法测序的测序是指测序的测序.太诺斯蒂克的核医学.

更多相关视频

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.0K

相关实验视频

Last Updated: Jun 26, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

8.8K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K
Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread
05:23

Author Spotlight: Decoding Metastasis-to-Metastasis Seeding Using a New In Vivo Technique for Tracking Breast Cancer Spread

Published on: July 7, 2023

1.0K

科学领域:

  • 核医学和瘤学的核医学和瘤学.
  • 分子向的放射性干疗法
  • 在癌症护理中的治疗术.

背景情况:

  • 核医学的治疗起源于用放射性治疗甲状腺癌.
  • 核医学中医生角色的复苏是由PSMA向的放射性连接体 (Ga-68/Lu-177/Ac-225) 推动的.
  • 癌症护理领域不断发展,在分子向治疗中强调精确的时间.

研究的目的:

  • 解决分子向放射性干疗法的进化和临床整合中的关键时机问题.
  • 强调对剂量计的精度和个性化治疗规划的需要.
  • 倡导开发用于转移性癌症的综合治疗方法.

主要方法:

  • 审查目前的治疗癌症护理景观.
  • 讨论 -omics专业知识和临床实践中的劳动力培训需求.
  • 探索针对瘤微环境的新型放射性分子,例如纤维细胞激活蛋白抑制剂.

主要成果:

  • 时间是有利于在瘤学中推进theranostics.
  • 对瘤和器官的个性化辐射吸收剂量 (Gy) 是必不可少的,远离固定活动 (GBq) 管理.
  • 组合测序的治疗-免疫-化疗策略对转移性癌症,特别是胰腺癌有前途.

结论:

  • 核医学的复兴需要专注于放射性连接体治疗的精确时间.
  • 个性化剂量测量和新型组合疗法对于优化癌症治疗结果至关重要.
  • 目前的环境非常有利于未来的发展和实施theranostics.